Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20201207049639N9Phase 3Completed
Phase 3, randomised, double-blind trial in Emergence agitation (EA) comparing Propofol, Ketamine and Ketofol (3 arms). Primary endpoint: Agitation score. Started Jul 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20201207049639N9.